{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:28:54Z","timestamp":1792697334152,"version":"4.5.0"},"reference-count":24,"publisher":"BMJ","issue":"e1","funder":[{"DOI":"10.13039\/501100004734","name":"Jewish General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2022,8,2]]},"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1136\/ejhpharm-2022-003378","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T17:21:19Z","timestamp":1661361679000},"page":"e97-e100","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Visual compatibility and particle counter evaluations of syringes of intramuscular psychotropic coadministered solutions"],"prefix":"10.1136","volume":"30","author":[{"given":"Lydia","family":"Djerroud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregoire","family":"Leclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8526-857X","authenticated-orcid":false,"given":"Vincent","family":"Dagenais-Beaul\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"2024052713174690000_30.e1.e97.1","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2011.9.6866"},{"key":"2024052713174690000_30.e1.e97.2","unstructured":"IBM Micromedex Solutions . IV compatibility. Greenwood Village, CO: IBM Corporation, 2021."},{"key":"2024052713174690000_30.e1.e97.3","unstructured":"Trissel LA . Handbook on injectable drugs. 20th ed. Bethesda, MD: American Society of Health-System Pharmacists, 2018."},{"key":"2024052713174690000_30.e1.e97.4","unstructured":"King JC , Catania PN . King guide to parenteral Admixtures. 14th ed. King Guide Publications, Inc, 2014."},{"key":"2024052713174690000_30.e1.e97.5","unstructured":"Albano D . Manager, drug information, Wyeth-Ayerst laboratories): personal communication. Data on file. TriPharma 1994."},{"key":"2024052713174690000_30.e1.e97.6","first-page":"2962","article-title":"Compatibility of haloperidol lactate with benztropine mesylate","volume":"51","author":"Jackson","year":"1994","journal-title":"Am J Hosp Pharm"},{"key":"2024052713174690000_30.e1.e97.7","first-page":"2709","article-title":"Visual compatibility of neuroleptics with anticholinergics or antihistamines in polyethylene syringes","volume":"51","author":"Gibler","year":"1994","journal-title":"Am J Hosp Pharm"},{"key":"2024052713174690000_30.e1.e97.8","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502901119"},{"key":"2024052713174690000_30.e1.e97.9","first-page":"294","article-title":"Visual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injection","volume":"27","author":"Halpern","year":"1989","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"2024052713174690000_30.e1.e97.10","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070067"},{"key":"2024052713174690000_30.e1.e97.11","unstructured":"Lighthouse Worldwide Solutions Inc . LS-20 liquid sampler system \u2013 operating manual; 2010."},{"key":"2024052713174690000_30.e1.e97.12","unstructured":"United States Pharmacopoeia and National Formulary . Particulate Matter in Injections <788>. Rockville, MD The United States Pharmacopoeial Convention; 2020."},{"key":"2024052713174690000_30.e1.e97.13","first-page":"238","article-title":"Physical compatibility of medications used in critically ill patients with balanced fluid solutions","volume":"24","author":"Wilder","year":"2020","journal-title":"Int J Pharm Compd"},{"key":"2024052713174690000_30.e1.e97.14","unstructured":"Elbe D , Cond\u00e9 C . Visual compatibility of various injectable neuroleptics agents with benztropine and lorazepam in polypropylene syringes. The Canadian Journal of Hospital Pharmacy 2001:54\u20132."},{"key":"2024052713174690000_30.e1.e97.15","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E124"},{"key":"2024052713174690000_30.e1.e97.16","unstructured":"United States Pharmacopoeia and National Formulary . Pharmaceutical Compounding \u2013 Sterile Preparations <797>. Rockville, MD The United States Pharmacopoeial Convention; 2019."},{"key":"2024052713174690000_30.e1.e97.17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1515\/pthp-2019-0005","article-title":"Physical compatibility of intravenous drugs commonly used in intensive care units: an observational study and physical compatibility laboratory tests on anti-infective drugs","volume":"4","author":"D\u2019Huart","year":"2019","journal-title":"Pharmaceutical Technology in Hospital Pharmacy"},{"key":"2024052713174690000_30.e1.e97.18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1310\/hpj5003-214","article-title":"Compatibility of cloxacillin sodium with selected intravenous drugs during simulated Y-Site administration","volume":"50","author":"Sullivan","year":"2015","journal-title":"Hosp Pharm"},{"key":"2024052713174690000_30.e1.e97.19","first-page":"91","article-title":"Physical compatibilities of preanesthetic medications","volume":"29","author":"Parker","year":"1976","journal-title":"Can J Hosp Pharm"},{"key":"2024052713174690000_30.e1.e97.20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.18773\/austprescr.2008.057","article-title":"To mix or not to mix \u2013 compatibilities of parenteral drug solutions","volume":"31","author":"Murney","year":"2008","journal-title":"Australian Prescriber"},{"key":"2024052713174690000_30.e1.e97.21","first-page":"2298","article-title":"Visual compatibility of midazolam hydrochloride with common preoperative injectable medications","volume":"44","author":"Forman","year":"1987","journal-title":"Am J Hosp Pharm"},{"key":"2024052713174690000_30.e1.e97.22","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080245"},{"key":"2024052713174690000_30.e1.e97.23","unstructured":"Flahive E . Medical information, Ortho-McNeil: personal communication TriPharma; 1995."},{"key":"2024052713174690000_30.e1.e97.24","doi-asserted-by":"publisher","DOI":"10.1177\/106002809603000529"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2022-003378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T20:17:57Z","timestamp":1716841077000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2022-003378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":24,"journal-issue":{"issue":"e1","published-online":{"date-parts":[[2023,3,19]]},"published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1136\/ejhpharm-2022-003378"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2022-003378","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]}}}